FDA Inspection 868769 — Zhejiang Orient Gene Biotech
The FDA completed an inspection of Zhejiang Orient Gene Biotech on Jan 17, 2014 in Huzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2014
- Fiscal Year
- 2014
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Huzhou (China)